The effect of L-arginine on arterial stiffness and oxidative stress in chronic kidney disease

Indian Journal of Nephrology

Volumn 22, Issue 5, 2012, Pages 340-346

  Annavarajula, S K ^a,b   Dakshinamurty, K V ^a   Naidu, M U R ^a   Prabhakar Reddy, C ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^b Yashoda Hospital   (India)

Author keywords

Arterial stiffness; chronic kidney disease; L arginine; oxidative stress; pulse wave velocity

Indexed keywords

ANTIHYPERTENSIVE AGENT; ARGININE; MALONALDEHYDE; NITRIC OXIDE;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ANTIOXIDANT ACTIVITY; AORTA PRESSURE; ARTERIAL STIFFNESS; ARTICLE; BLOOD LEVEL; CAROTID ARTERY; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENDOTHELIAL DYSFUNCTION; FEMALE; FEMORAL ARTERY; HEART RATE; HUMAN; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; OXIDATIVE STRESS; PULSE WAVE; RADIAL ARTERY; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

EID: 84871770295     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.103907     Document Type: Article

References (29)

1. Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, et al. The burden of kidney disease: improving global outcomes. Kidney Int 2004;66:1310-4. (Pubitemid 39302630)
2. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998;32:S112-S9.
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
4. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27:2588-605. (Pubitemid 44627304)
5. Aiello S, Noris M, Todeschini M, Zappella S, Foglieni C, Benigni A, et al. Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int 1997;52:171-81. (Pubitemid 27321828)
6. Reyes AA, Purkerson ML, Karl I, Klahr S. Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am J Kidney Dis 1992:20:168-76.
7. Ashab I, Peer G, Blum M, Wollman Y, Chernihovsky T, Hassner A, et al. Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int 1995;47:1515-21.
8. Reyes AA, Martin D, Settle S, Klahr S. EDRF role in renal function and blood pressure of normal rats and rats with obstructive uropathy. Kidney Int 1992;41:403-13.
9. Zhou MS, Adam AG, Jaimes EA, Raij L. In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II. Hypertension 2003;42:945-51. (Pubitemid 37413735)
10. Hayakawa H, Hirata Y, Suzuki E, Kimura K, Kikuchi K, Nagano T, et al. Long-term administration of L-arginine improves nitric oxide release from kidney in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1994;23:752-6. (Pubitemid 24180806)
11. Shinohara K, Shoji T, Tsujimoto Y, Kimoto E, Tahara H, Koyama H, et al. Arterial stiffness in predialysis patients with uremia. Kidney Int 2004;65:936-43. (Pubitemid 38251069)
12. Covic A, Goldsmith DJ, Gusbeth-Tatomir P, Covic M. Hemodialysis acutely improves endothelium-independent vasomotor function without significantly influencing the endothelium-mediated abnormal response to a beta 2-agonist. Nephrol Dial Transplant 2004;19:637-43. (Pubitemid 38263124)
13. Benetos A, Adamopoulos C, Bureau JM, Temmar M, Labat C, Bean K, et al. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 2002;105:1202-7. (Pubitemid 34225821)
14. Peters H, Border WA, Rückert M, Krämer S, Neumayer HH, Noble NA. L-arginine supplementation accelerates renal fibrosis and shortens life span in experimental lupus nephritis. Kidney Int 2003;63:1382-92. (Pubitemid 36350003)
15. Peters H, Border WA, Noble NA. From rats to man: a perspective on dietary L-arginine supplementation in human renal disease. Nephrol Dial Transplant 1999;14:1640-50. (Pubitemid 29313040)
16. Katoh T, Takahashi K, Klahr S, Reyes AA, Badr KF. Dietary supplementation with L-arginine ameliorates glomerular hypertension in rats with subtotal nephrectomy. J Am Soc Nephrol 1994;4:1690-4.
17. Savage MT, Ferro CJ, Pinder SJ, Tomson CR. Reproducibility of derived central arterial waveforms in patients with chronic renal failure. Clin Sci (Lond) 2002;103:59-65. (Pubitemid 34729125)
18. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995;26:485-90.
19. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R, et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004;109:184-9. (Pubitemid 38114137)
20. Blacher J, Safar ME, Guerin AP, Pannier B, Marchais SJ, London GM. Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 2003;63:1852-60. (Pubitemid 36513333)
21. Townsend RR, Wimmer NJ, Chirinos JA, Parsa A, Weir M, Perumal K, et al. Aortic PWV in chronic kidney disease: a CRIC ancillary study. Am J Hypertens 2010;23:282-9.
22. Shinohara K, Shoji T, Tsujimoto Y, Kimoto E, Tahara H, Koyama H, et al. Arterial stiffness in predialysis patients with uremia. Kidney Int 2004;65:936-43. (Pubitemid 38251069)
23. Wang MC, Tsai WC, Chen JY, Huang JJ. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis 2005;45;494-501.
24. Peters H, Wyane A. Borders, Tandem antifibrotic actions of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis. Kidney Int 2000;57:992-1001. (Pubitemid 30434789)
25. Mullen MT, Wright D, Donald AE, Thorne S, Thomson H, Deanfield JE. Atorvastatin but not L-arginine improves endothelial function in type 1 diabetes: a double-blind study. J Am Coll Cardiol 2000;36:410-6. (Pubitemid 30624000)
26. Blum A, Hathway L, Mincemoyer R, Schenke WH, Kirby M, Csako G, et al. Oral L-arginine in patients with coronary artery disease on medical management. Circulation 2000;101:2160-4. (Pubitemid 30253044)
27. Bennett-Richards KJ, Kattenhorn M, Donald AE, Oakley GR, Varghese Z, Bruckdorfer KR, et al. Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure. Kidney Int 2002;62:1372-8.
28. Maxwell AJ, Zapien MP, Pearce GL, MacCallum G, Stone PH. Randomized trial of medical food for dietary management of chronic, stable angina. J Am Coll Cardiol 2002;39:37-45. (Pubitemid 34061906)
29. Rhoden EL, Lucas ML, Pereira-Lima L, Rhoden CR, Souto CA. Effects of L-arginine on the kidney levels of malondialdehyde in rats submitted to renal ischaemia-reperfusion. BJU Int 2001;88:273-7. (Pubitemid 32863053)